Article Details
Retrieved on: 2021-03-21 15:03:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Tocilizumab, a monoclonal antibody that blocks IL-6 receptors and appears to tamp down the inflammation seen in COVID-19, is now approved as a ...
Article found on: www.contagionlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here